|
|
Gene Symbol |
VDR |
|
Aliases |
NR1I1, PPP1R163 |
|
Entrez Gene ID |
|
|
Gene Name |
Vitamin D receptor |
|
Chromosomal Location |
12q13.11 |
|
HGNC ID |
|
|
Summary |
This gene encodes vitamin D3 receptor, which is a member of the nuclear hormone receptor superfamily of ligand-inducible transcription factors. This receptor also functions as a receptor for the secondary bile acid, lithocholic acid. Downstream targets of vitamin D3 receptor are principally involved in mineral metabolism, though this receptor regulates a variety of other metabolic pathways, such as those involved in immune response and cancer. Mutations in this gene are associated with type II vitamin D-resistant rickets. A single nucleotide polymorphism in the initiation codon results in an alternate translation start site three codons downstream. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. A recent study provided evidence for translational readthrough in this gene, and expression of an additional C-terminally extended isoform via the use of an alternative in-frame translation termination codon. [provided by RefSeq, Jun 2018]
|
|
RefSeq DNA |
|
|
RefSeq mRNA |
|
|
e!Ensembl
|
SNPs
SNP Id |
Upstream Sequence |
SNP |
Downstream Sequence |
Functional Significance |
References |
rs731236 |
CCTGGGGTGCAGGACGCCGCGCTGAT |
C/T |
GAGGCCATCCAGGACCGCCTGTCCA |
Synonymous codon,upstream variant 2KB |
24078159, 21082232 | |
rs10735810 |
CCTGGGGTGCAGGACGCCGCGCTGAT |
C/T |
GAGGCCATCCAGGACCGCCTGTCCA |
M1T |
21082232 | |
rs1544410 |
CCTGGGGTGCAGGACGCCGCGCTGAT |
C/T |
GAGGCCATCCAGGACCGCCTGTCCA |
Intron variant,upstream variant 2KB |
21082232 | |
rs7975232 |
GAAGGCACAGGAGCTCTCAGCTGGGC |
A/C |
CCTCACTGCTCAATCCCACCACCCC |
Intron variant,upstream variant 2KB |
21082232, 28127831 | |
rs757343 |
TTTGGAGGCAATGTGCAGTGACCCTT |
A/G |
ACCTCTTCCGCTGGTTAGAGGTGAG |
Intron variant,upstream variant 2KB |
21082232, 23246977 | |
|
Gene Ontology (GO)
GO ID |
Ontology |
Function |
Evidence |
Reference |
GO:0000122 |
Biological process |
Negative regulation of transcription by RNA polymerase II |
IDA |
17426122 |
GO:0000902 |
Biological process |
Cell morphogenesis |
IMP |
17223341 |
GO:0007165 |
Biological process |
Signal transduction |
TAS |
2849209 |
GO:0007275 |
Biological process |
Multicellular organism development |
IBA |
21873635 |
GO:0008285 |
Biological process |
Negative regulation of cell proliferation |
IDA |
16549446 |
GO:0009887 |
Biological process |
Animal organ morphogenesis |
IBA |
21873635 |
GO:0010628 |
Biological process |
Positive regulation of gene expression |
IMP |
17223341 |
GO:0010839 |
Biological process |
Negative regulation of keratinocyte proliferation |
IMP |
17223341 |
GO:0010980 |
Biological process |
Positive regulation of vitamin D 24-hydroxylase activity |
IDA |
16549446 |
GO:0030154 |
Biological process |
Cell differentiation |
IBA |
21873635 |
GO:0038183 |
Biological process |
Bile acid signaling pathway |
IDA |
12016314 |
GO:0045618 |
Biological process |
Positive regulation of keratinocyte differentiation |
IMP |
17082781 |
GO:0045892 |
Biological process |
Negative regulation of transcription, DNA-templated |
IDA |
11891224 |
GO:0045944 |
Biological process |
Positive regulation of transcription by RNA polymerase II |
IBA |
21873635 |
GO:0045944 |
Biological process |
Positive regulation of transcription by RNA polymerase II |
IMP |
17082781, 17254542 |
GO:0046697 |
Biological process |
Decidualization |
IEP |
16720713 |
GO:0070561 |
Biological process |
Vitamin D receptor signaling pathway |
IDA |
16549446 |
GO:0070561 |
Biological process |
Vitamin D receptor signaling pathway |
IMP |
28698609 |
GO:0005634 |
Cellular component |
Nucleus |
IBA |
21873635 |
GO:0005634 |
Cellular component |
Nucleus |
IDA |
15589699, 17082781 |
GO:0043235 |
Cellular component |
Receptor complex |
IDA |
17426122 |
GO:0090575 |
Cellular component |
RNA polymerase II transcription factor complex |
IBA |
21873635 |
GO:0090575 |
Cellular component |
RNA polymerase II transcription factor complex |
IDA |
17426122 |
GO:0000976 |
Molecular function |
Transcription regulatory region sequence-specific DNA binding |
IBA |
21873635 |
GO:0000977 |
Molecular function |
RNA polymerase II regulatory region sequence-specific DNA binding |
IBA |
21873635 |
GO:0000981 |
Molecular function |
DNA-binding transcription factor activity, RNA polymerase II-specific |
IBA |
21873635 |
GO:0000981 |
Molecular function |
DNA-binding transcription factor activity, RNA polymerase II-specific |
ISM |
19274049 |
GO:0000981 |
Molecular function |
DNA-binding transcription factor activity, RNA polymerase II-specific |
NAS |
19274049 |
GO:0003677 |
Molecular function |
DNA binding |
IDA |
11891224 |
GO:0003700 |
Molecular function |
DNA-binding transcription factor activity |
IDA |
17426122 |
GO:0004879 |
Molecular function |
Nuclear receptor activity |
IDA |
12016314, 16549446, 17082781 |
GO:0004879 |
Molecular function |
Nuclear receptor activity |
IMP |
28698609 |
GO:0005499 |
Molecular function |
Vitamin D binding |
IBA |
21873635 |
GO:0005515 |
Molecular function |
Protein binding |
IPI |
9632709, 9653119, 10409738, 10744685, 10866662, 12840015, 17254542, 17426122, 20089040, 20227041, 20413580, 21119599, 21478865, 21988832, 22179700, 25910212, 27728806 |
GO:0008134 |
Molecular function |
Transcription factor binding |
IBA |
21873635 |
GO:0030374 |
Molecular function |
Nuclear receptor transcription coactivator activity |
IBA |
21873635 |
GO:0038023 |
Molecular function |
Signaling receptor activity |
IBA |
21873635 |
GO:0038023 |
Molecular function |
Signaling receptor activity |
IDA |
16549446 |
GO:0038186 |
Molecular function |
Lithocholic acid receptor activity |
IDA |
12016314 |
GO:0046965 |
Molecular function |
Retinoid X receptor binding |
IDA |
28698609 |
GO:0046965 |
Molecular function |
Retinoid X receptor binding |
IPI |
17426122 |
GO:0070644 |
Molecular function |
Vitamin D response element binding |
IBA |
21873635 |
GO:0070644 |
Molecular function |
Vitamin D response element binding |
IDA |
17426122 |
GO:1902098 |
Molecular function |
Calcitriol binding |
IBA |
21873635 |
GO:1902098 |
Molecular function |
Calcitriol binding |
IDA |
10678179, 12016314 |
GO:1902098 |
Molecular function |
Calcitriol binding |
IMP |
28698609 |
GO:1902121 |
Molecular function |
Lithocholic acid binding |
IDA |
12016314 |
|
Protein Information |
|
Protein Name |
Vitamin D3 receptor, 1,25-dihydroxyvitamin D3 receptor, nuclear receptor subfamily 1 group I member 1, protein phosphatase 1, regulatory subunit 163, vitamin D (1,25- dihydroxyvitamin D3) receptor, vitamin D nuclear receptor variant 1 |
|
Function |
Nuclear receptor for calcitriol, the active form of vitamin D3 which mediates the action of this vitamin on cells (PubMed:28698609, PubMed:16913708, PubMed:15728261, PubMed:10678179). Enters the nucleus upon vitamin D3 binding where it forms heterodimers with the retinoid X receptor/RXR (PubMed:28698609). The VDR-RXR heterodimers bind to specific response elements on DNA and activate the transcription of vitamin D3-responsive target genes. Plays a central role in calcium homeostasis |
|
|
|
|
|
UniProt |
|
|
PDB |
1YNW, 1DB1, 1IE8, 1IE9, 1KB2, 1KB4, 1KB6, 1S0Z, 1S19, 1TXI, 2HAM, 2HAR, 2HAS, 2HB7, 2HB8, 3A2I, 3A2J, 3A3Z, 3A40, 3A78, 3AUQ, 3AUR, 3AX8, 3AZ1, 3AZ2, 3AZ3, 3B0T, 3CS4, 3CS6, 3KPZ, 3M7R, 3OGT, 3P8X, 3TKC, 3VHW, 3W0A, 3W0C, 3W0Y, 3WGP, 3WWR, 3X31, 3X36, 4G2I, 4ITE, 4ITF, 5GT4, 5V39, 5YSY, 5YT2 |
|
|
|
Interactions |
| |
STRING |
MINT |
IntAct |
ENSP00000274793 |
|
Q13093 |
|
| |
View interactions
|
|
| |
Associated Diseases
Disease group | Disease Name | References |
Cardiovascular Diseases |
Hypertensive disease |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities |
Single-Gene Defects |
|
Hereditary Diseases |
|
Genetic Diseases |
|
Endocrine System Diseases |
PCOS |
|
Musculoskeletal Diseases |
Rickets |
2177843, 7828346, 8961271, 17970811, 8675579, 9005998, 8106618, 2849209, 8392085, 1652893, 8381803, 28698609, 3024987, 2557627, 9495519, 2558018, 9360557, 2174914, 8862631, 11564167, 1338926, 22466564, 17451081 |
Gout |
|
Neoplasms |
Breast Cancer |
|
Carcinoma |
|
Multiple Sclerosis |
|
Prostate cancer |
|
Leukemia |
|
Nervous System Diseases |
Brain Infarction |
|
Epilepsy |
|
Choroidal Artery Infarction |
|
Nutritional and Metabolic Diseases |
Vitamin D Deficiency |
|
Gluocose Intolerance |
|
Psychiatric/Brain disorders |
Narcolepsy |
|
Schizophrenia |
|
Bipolar Disorder |
|
Obstructive Sleep Apnea |
|
Renal Disorder |
Uremia |
|
Reproductive disorders |
Preeclampsia |
|
Skin and Connective Tissue Diseases |
Alopecia |
|
|
References |
|
|
|
PubMed ID |
Associated gene/s |
Associated condition |
Genetic Mutation |
Diagnostic Criteria |
Association with PCOS |
Ethnicity |
Conclusion |
|
CASR |
|
rs10735810, rs7975232, rs757343, rs731236 |
NICHD criteria |
Related
|
56 Iranian PCOS women |
This data indicated for the first time that it is possible that the VDR and CASR gene variants through their effects on LH and SHBG levels, and insulin resistance are involved in pathogenesis of PCOS |
|
|
|
rs731236 |
|
Direct
|
150 Egyptian women with PCOS, 150 unrelated controls |
The results suggested that, VDRTaq-I gene polymorphism is associated with increased risk of PCOS in Egyptian women |
|
|
|
rs757343 |
|
Related
|
260 PCOS women (cases), 221 normoovulatory women (controls) |
The genetic variant of the VDR was found to have an association with severity of clinical features of PCOS, but none with disease risk |
|
GC, DHCR7, CYP2R1 |
|
|
|
Related
|
545 PCOS, 145 control women |
VDR and vitamin D level-related variants are associated with metabolic and endocrine parameters including 25(OH)D levels in PCOSwomen |
|
|
|
|